These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23359475)

  • 21. Non-alcoholic fatty liver disease and the statins treatment.
    Dima A; Marinescu AG; Dima AC
    Rom J Intern Med; 2012; 50(1):19-25. PubMed ID: 22788090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of nonalcoholic fatty liver disease: current status.
    Duvnjak M; Tomasic V; Gomercic M; Smircic Duvnjak L; Barsic N; Lerotic I
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():57-66. PubMed ID: 20388946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?
    Domanski JP; Park SJ; Harrison SA
    J Clin Gastroenterol; 2012; 46(5):427-30. PubMed ID: 22469639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management.
    Lemoine M; Serfaty L; Capeau J
    Curr Opin Infect Dis; 2012 Feb; 25(1):10-6. PubMed ID: 22183113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Sugimoto K; Inui H; Fukusato T
    World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic fatty liver disease (NAFLD): a comprehensive review.
    Salt WB
    J Insur Med; 2004; 36(1):27-41. PubMed ID: 15104027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic criteria for non-alcoholic steatohepatitis].
    Hashimoto E
    Nihon Rinsho; 2006 Jun; 64(6):1025-32. PubMed ID: 16768105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is fatty liver always benign and should not consequently be treated?
    Fierbinteanu-Braticevici C; Negreanu L; Tarantino G
    J Physiol Pharmacol; 2013 Feb; 64(1):3-9. PubMed ID: 23568965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NAFLD in the absence of metabolic syndrome: different epidemiology, pathogenetic mechanisms, risk factors for disease progression?
    Yilmaz Y
    Semin Liver Dis; 2012 Feb; 32(1):14-21. PubMed ID: 22418884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nonalcoholic steatohepatitis--a "new" hepatic disease].
    Grønbaek H; Eivindson MV; Hamilton-Dutoit S; Vilstrup H
    Ugeskr Laeger; 2003 Mar; 165(11):1115-8. PubMed ID: 12677985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatty liver: role of inflammation and fatty acid nutrition.
    Byrne CD
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):265-71. PubMed ID: 20189787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history of nonalcoholic steatohepatitis.
    Liou I; Kowdley KV
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Steatosis and steatohepatitis in diabetic patient].
    Hůlek P; Dresslerová I
    Vnitr Lek; 2011 Apr; 57(4):364-7. PubMed ID: 21612059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets.
    Younossi ZM; Reyes MJ; Mishra A; Mehta R; Henry L
    Aliment Pharmacol Ther; 2014 Jan; 39(1):3-14. PubMed ID: 24206433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic options for nonalcoholic fatty liver disease and steatohepatitis].
    Kluwe J; Lohse AW
    Internist (Berl); 2005 Dec; 46(12):1324-30. PubMed ID: 16247633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
    Serfaty L; Lemoine M
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
    Crespo M; Lappe S; Feldstein AE; Alkhouri N
    Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic fatty liver disease.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2002; 2(1):11-9. PubMed ID: 12122975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens.
    Martín-Castillo A; Castells MT; Adánez G; Polo MT; Pérez BG; Ayala I
    Biomed Pharmacother; 2010 Apr; 64(4):275-81. PubMed ID: 19932590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
    McCullough AJ
    Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.